Background: Measurement of magnesium (Mg) status is problematic because tissue Mg deficiency can be present without low serum Mg concentrations. Objective: To evaluate a modified version of the Mg retention test using stable isotopes for the assessment of Mg status in general, and the detection of marginal Mg deficiency in particular. Design: A modified version of the Mg retention test using a small dose of 26 Mg was evaluated for assessment of Mg status in 22 healthy subjects. Muscle Mg concentration was used as reference for Mg status. A muscle biopsy was taken from the lateral portion of the quadriceps muscle from each subject. After 2 to 4 weeks, 11 mg of 26 Mg (as MgCl 2 in 14 ml water) were injected i.v. over a period of 10 min and all urine was collected for the following 24 h. Excretion of the isotopic label was expressed as percentage of the administered dose excreted in urine within 24 h. Results: Mean7s.d. Mg concentration in muscle was 3.8570.17 mmol/100 g fat-free dried solids. Mean7s.d. excretion of the injected dose within 24 h was 7.972.1%. No correlation was found between muscle Mg concentration and excretion of the isotopic label (r 2 ¼ 0.061, P ¼ 0.27). Conclusions: In this study, urinary excretion of an intravenous Mg tracer was not influenced by muscle Mg concentration and its usefulness for the detection of marginal Mg deficiency could therefore not be demonstrated. Sponsorship:
Introduction
Magnesium (Mg) deficiency has been observed in various diseases such as diabetes, hypertension, cardiovascular disease or alcoholism (Nadler and Rude, 1995; Shils, 1998) . Measurement of Mg status however remains problematic. Mg is principally an intracellular cation, with less than 1% of its total body content present in the extracellular fluids. The Mg concentration in serum represents only a small fraction (0.3%) of total body Mg (Shils, 1998) and is subject to tight homeostatic regulation. As a result, serum Mg concentration is an insensitive indicator of Mg status, and it does not correlate with any other tissue pool of Mg except for interstitial fluid (Elin, 1987) . Nevertheless, serum or plasma Mg measurement is the most widely used test for Mg status because it is easy and inexpensive to perform. Severe Mg deficiency is usually detected by low serum Mg concentrations; however, when Mg deficiency is marginal, serum Mg values can be normal despite depletion of intracellular Mg (Dyckner and Wester, 1982; Resnick et al., 1993) .
Since 99% of total body Mg is intracellular, determination of intracellular Mg appears to be a better indicator of Mg status than serum Mg concentration. Muscle and bone contain the majority of body Mg and are therefore potentially important tissues for assessment of status. However, muscle and bone biopsies are invasive and timeconsuming. Measurement of intracellular Mg in blood cells such as erythrocytes and leukocytes has been proposed as a less-invasive approach, but results are equivocal (Elin, 1991) .
Considering the lack of simple techniques to reliably measure Mg status, the Mg load test has been proposed as an alternative (Jones et al., 1969; Lim and Jacob, 1972; Bohmer and Mathiesen, 1982; Ryzen et al., 1985; Gullestad et al., 1992; Lasserre et al., 1996) . It is a physiological assessment method and consists of measuring the retention of a parenterally administered dose of Mg. In general, 5-30 mmol of Mg are infused over several hours, and the Mg content in 24 h urine is determined to calculate the retention of the administered load. Mg deficiency results in a higher retention of the intravenous load. Mg load tests have been applied and validated by several authors as method for the determination of Mg status (Jones et al., 1969; Lim and Jacob, 1972; Bohmer and Mathiesen, 1982; Ryzen et al., 1985; Gullestad et al., 1992; Lasserre et al., 1996) . Retention of the intravenous load has shown to correlate with Mg concentration in skeletal muscle in Mg-deficient patients (Jones et al., 1969; Lim and Jacob, 1972; Jeppesen, 1986; Holm et al., 1987; Sjogren et al., 1988 ). However, a major disadvantage of the load test is that it is affected by dietary Mg intake, as well as basal urinary Mg and fecal Mg excretion, all of which have an influence on the urinary Mg excretion after an i.v. loading dose. Moreover, the Mg load test is time-consuming and requires hospitalization of the subjects for dose administration.
The aim of the present study was to assess a modification and simplification of the Mg retention test. When using a stable Mg isotope for i.v. administration, the potential confounding effects of dietary Mg intake and basal urinary Mg are minimized. Consequently, a much lower dose can be administered by injection over a few minutes in an ambulatory setting. For validation, muscle Mg concentration was used as the accepted reference technique, being a reliable indicator for Mg status (Lim et al., 1969; Dyckner and Wester, 1985) .
Subjects, methods and materials

Subjects
In total, 50 healthy subjects were recruited from the student population of the Swiss Federal Institute of Technology (ETH) and the University of Zurich. A venous blood sample was taken for determination of plasma Mg concentrations. In order to assure a broad range of plasma Mg among the subjects, 22 subjects (11 women, 11 men) were selected. Plasma Mg concentrations ranged from 0.68 to 0.95 mmol/l. Exclusion criteria included cardiovascular, hepatic, bleeding, metabolic and/or renal disorders, pregnancy and lactation, and blood donations less than 3 weeks before the study. Baseline characteristics of the 22 selected subjects are shown in Table 1 . No medication (except oral contraceptives) or vitamin/mineral supplements were consumed during the entire study. Written informed consent was obtained from each subject and the study protocol was approved by the Ethical Committee of the Swiss Federal Institute of Technology (ETH) Zurich.
Study protocol
At 2 to 4 weeks prior to the test, a muscle biopsy was taken from the lateral portion of the quadriceps muscle using a slight modification of the method described by Bergström (1962) . The biopsy was taken with a 14 G biopsy needle (ACN1410MF, Medical Device Technologies Inc., Gainesville, FL, USA) and a special biopsy device (Pro-Mag 2.2, Manan Medical Products, Northbrook, IL, USA). Skin and subcutaneous tissue were locally anaesthetized with 10 ml mepivacain HCl 1% (produced by the pharmacy of the University Hospital Zurich). A muscle sample weighing between 13.2 and 34.5 mg of fresh muscle tissue was obtained. After biopsy, visible connective tissue or fat was dissected and removed, and the muscle samples were transferred in plastic vials and frozen at À251C. All possible precautions for avoiding sample contamination were taken, including the use of acid washed materials.
The day before the test a urine spot sample was collected for determination of the baseline Mg isotope ratios. A standardized vegetarian diet and mineral water (20 mg Mg/l) were provided for the entire day (Table 2 ). Weight and height of each subject were measured. After an overnight fast, 11 mg of 26 Mg (as MgCl 2 in 14 ml water) was injected i.v. over a period of 10 min. A sterile injection system consisting of a two-way catheter and a septum injection port was used. The isotope solution was injected quantitatively by flushing the system with physiological saline (10 ml). The exact amount of injected isotopic label was determined by weighing the syringe before and after injection. No food or drink was allowed for 1 h following the isotope administration. A standardized diet and mineral water were provided for the remainder of the day (Table 2) . Following injection, the subjects collected all urine in preweighed polyethylene bottles for 24 h. Bottles for urine collection (2 l volume) contained 10 ml concentrated HCl to reduce precipitation. Exactly 24 h after injection, the subjects voided urine and then terminated the collection. Between 22 and 25 h after injection, a fasting venous blood sample was taken.
Habitual mean daily Mg intake of each subject was assessed by diet history using a computer-aided interview. We used the EBIS computer software (Version 4.0, University of Hohenheim, Stuttgart, Germany), which is based on the German Food and Nutrient Database BLS 2.3 (Bundesinstitut für gesundheitlichen Verbraucherschutz und Veterinärmedi-zin, Berlin, Germany). The subjects were asked to give detailed information about their eating habits during the previous 2 months. The method has been validated for Mg (Landig et al., 1998) and has been described in detail previously (Wälti et al., 2002) .
Materials
Reagents. All chemicals used were of analytical grade. Nitric acid and hydrochloric acid were further purified by subboiling distillation. All water used for analytical procedures was purified by ion exchange and reverse osmosis (18 MO) (RD2000, Renggli AG, Rotkreuz, Switzerland; Nanopure Cartridge System, Skan AG, Basel, Switzerland). Acid-washed labware was used for urine, blood and muscle sample analyses.
Isotopic label. Mg isotope ratio is not altered significantly by addition of the label. Following, the 26 MgCl 2 was dried down and heated in a muffle furnace (thermicon P, Heraeus GmbH, Hanau, Switzerland) at 2501C for 30 min to destroy pyrogenes. Doses for i.v. administration were prepared in a sterile environment at the pharmacy of the University Hospital, Zurich. The isotopic label was redissolved in sterile water, acidified with HCl 32% until complete dissolution and neutralized by adding NaHCO 3 . The final injection solution contained 0.78 mg Mg/ml and had a pH of 6.3. The solution was sterilized by filtration, divided into individual doses of 15 ml, transferred into glass vials, capped and sealed. After preparation of the solution, the isotopic composition was verified by thermal ionization mass spectrometry (TIMS, see below).
Sample preparation and analysis Sampling of urine and blood samples. All urine samples were weighed and mechanically shaken for at least 1 h before pooling. The 24-h urine pools were prepared by combining 5% of each sample (by weight) and were stored at À251C. Venous blood samples at baseline and 24 h after isotope injection were drawn in heparinized tubes (10 ml). Plasma was separated from blood cells by centrifugation at 3000 r.p.m. for 15 min (Omnifuge 2.0 RS, Heraeus GmbH, Hanau, Switzerland) and stored in plastic vials at À251C until analysis. Quantitative analysis of baseline Mg in plasma was carried out by flame atomic absorption spectrometry (AAS) (SpectrAA 400, Varian, Mulgrave, Australia) at 285.2 nm, using parameters recommended by the manufacturer (Varian Techtron Pty. Limited, 1989) . A commercial Mg standard (CertiPUR, Merck, Darmstadt, Germany) was used for internal calibration by standard addition to minimize matrix effects. Plasma samples were diluted 200-fold so that the Mg concentrations of the final diluted solutions were in the range of 0.1-0.4 mg/ml. Lanthanum nitrate (Fluka Chemie GmbH, Buchs, Switzerland) was added as a matrix modifier (5 mg La/ml in the final solutions), and 0.1% Triton X-100 solution (Fluka Chemie GmbH) to reduce the surface tension. Samples were analyzed in duplicate and repeated if the difference between individual values relative to the mean was 47.5%.
Mineralization. Aliquots of urine pools (3 ml) and of blood plasma drawn after isotope injection (1 ml) were mineralized in duplicate using a mixture of concentrated nitric acid and H 2 O 2 (30%, suprapur quality, Merck) in a microwave digestion system (MLS-ETHOS plus, MLS GmbH, Leutkirch, Germany). Total Mg content of the mineralized samples was Preparation for isotopic analysis. For Mg isotopic analysis, Mg was separated from the mineralized samples by cation-exchange chromatography using a strongly acidic ion-exchange resin as described previously (Bohn et al., 2004) . Aliquots of the mineralized samples were evaporated to dryness in Teflon vials, the residue dissolved in 1.0 ml 0.7 mol/l HCl and loaded on commercial Pyrex columns (Econo column, 1.0 cm Â 10 cm, Bio-Rad, Hercules, CA, USA) filled with ion-exchange resin (AG 50 W X-8, 200-400 mesh, Bio-Rad). After eluting Na and K with 0.7 and 0.9 mol/l HCl, Mg was eluted with 1.4 mol/l HCl. The Mg fraction was evaporated to dryness in Teflon vials, the residue dissolved in 0.5 ml concentrated HCl, transferred to Eppendorff tubes, evaporated to dryness in a furnace at 701C (WTBbinder, Tuttlingen, Germany) and redissolved in water.
Isotopic analysis by TIMS. Isotope ratios were determined by TIMS with a single-focusing magnetic sector field instrument (MAT 262, Finnigan MAT, Bremen, Germany) equipped with a Faraday cup multiple collector device for simultaneous ion beam detection. About 20 nmol separated Mg from urine/plasma samples was loaded onto the metal surface of the evaporation filament of a double-rhenium filament ion source. Mg was coated with 5-10 mg silicagel, 0.8 mmol boric acid and 30 nmol aluminum as AlCl 3 (all chemicals from Merck). Each measurement consisted of 50 consecutive isotope ratio measurements. Systematic isotope fractionation effects in the ion source were corrected by internal normalization technique using an exponential law (Russell et al., 1978 Creatinine analysis. Creatinine concentrations of the urine samples were determined using the method described by Jaffé (1886), which is based on the formation of a colored complex between picric acid (Riedel-de Haën, Buchs, Switzerland) and creatinine. A four-point external calibration curve was established using a commercial creatinine powder (Fluka Chemie GmbH). Analysis was carried out with a spectrophotometer (Uvikon 940, Kontron Instruments, Rotkreuz, Switzerland) measuring the colored complex at 520.0 nm.
Analysis of muscle samples. Frozen muscle samples were freeze-dried (Lyolab B, LSL Secfroid SA, Aclens-Lausanne, Switzerland). Milligram quantities of dried and temperature equilibrated samples were weighed on an analytical balance (Mettler UMT5, Mettler-Toledo AG, Greifensee, Switzerland; readability 0.1 mg) in an air temperature and air humidity controlled balance room. To correct for air buoyancy, the atmospheric parameters air temperature, air pressure and relative air humidity were determined using a precision climatic instrument (Klimet A30, Meteolabor AG, Wetzikon, Switzerland) (Wunderli et al., 2003) . The samples were mineralized in 1 ml HNO 3 65% for at least 40 h and filled up to 7 ml with HNO 3 2%. Of this solution, 1 ml was used for analysis. Dilution steps were performed gravimetrically (AT201, Mettler-Toledo AG; readability 0.1 mg). Quantitative analysis of Mg was carried out by optical emission spectrometry using an inductively coupled plasma (ICP-OES) (Optima 3000, Perkin-Elmer, Norwalk, CT, USA) and an ultrasonic nebulizer (U-5000 AT þ, Cetac Technologies Inc., Omaha, NE, USA). Measurements were carried out at three different wavelengths, 279.553, 280.271 and 285.213 nm. Only acid-washed PFA (perfluoro alkoxy alkane) tubes were used for the dilutions. Internal calibration by standard addition with 5 points was used for three samples to minimize matrix effects, and the concentrations of the remaining samples were calculated based on the mean of the three slopes of the standard addition curves. Scandium was used as internal standard (0.5 ppm). Dilutions and measurements were carried out twice on different days.
Data and statistical analysis
Excretion of the isotopically labeled Mg was calculated based on the amount ratio of isotopic label to natural Mg present in 24-h urinary pools and isotope dilution principles (Bohn et al., 2004) . The amount of 26 Mg isotopic label in each urine sample was calculated from the amount ratio of 26 Mg isotopic label to natural Mg determined by TIMS and the total Mg amount in urine determined by AAS. Mg excretion was expressed as the percentage of administered dose excreted in urine within 24 h. Distribution of the isotopic label in the rapidly exchangeable pools excluding plasma within 24 h was calculated by subtracting the amount of isotopic label in the urine pool and the amount in plasma from the injected dose. Endogenous intestinal losses were not accounted for. Plasma volume was calculated using empiric formulas based on sex, weight and height (Wennesland et al., 1959; Brown et al., 1962) .
26
Mg excretion was compared to muscle Mg to test for correlation.
Data processing and statistical analysis were carried out using Excel 2002 (Microsoft Corp., Seattle, WA, USA) and SPSS for Windows 11.0 (SPSS Inc., Chicago, IL, USA). Normal distribution of data was verified by calculating the quotient of the skewness divided by its standard error. Normal distribution can be assumed when this quotient lies between À2.5 and þ 2.5. Data were expressed as arithmetic means7s.d. Correlations were evaluated using Pearson's correlation coefficient, differences between men and women using unpaired Student's t-test. ANOVA was carried out to test for associations with muscle Mg concentration and excretion of the isotopic label as dependent variables. Correlations, differences and associations were considered statistically significant at Po0.05.
Results
The mean7s.d. habitual daily Mg intake in the men and women was 438761 and 4647138 mg, respectively. The recommended dietary intake for Switzerland (350 mg for adult men, 300 mg for adult women (D-A-CH, 2000)) was met by all but one subject. The extent of under/ over-reporting was estimated by comparing the reported individual energy intakes with mean estimated energy requirements (James and Schofield, 1990 ) using physical activity levels calculated according to reported activities. In the men, mean7s.d. reported energy intake (11 2907840 kJ) was 0.177.7% higher than estimated energy requirement. In the women, mean7s.d. reported energy intake (88707 1160 kJ) was 4.8710.9% lower than estimated energy requirement.
Mean7s.d. Mg concentration in muscle was 3.8570.17 mmol/100 g fat-free dried solids (FFDS). There was no significant difference between men and women. Mean7s.d. excretion of the injected dose within 24 h was 7.972.1%. Mean7s.d. distribution in the rapidly exchanging pools excluding plasma after 24 h was 90.772.1%. For other measured parameters such as total urinary Mg excretion and plasma Mg concentrations, see Table 3 . There was no correlation between muscle Mg concentration and excretion of the isotopic label within 24 h (r 2 ¼ 0.061, P ¼ 0.27) (Figure 1 ). The same result was obtained when men and women were analyzed separately, when Mg excretion was corrected by creatinine output or body weight. Either, no correlation could be found between muscle Mg concentration and distribution of the isotopic label in the rapidly exchangeable pools excluding plasma (r 2 ¼ 0.061, P ¼ 0.27) or between muscle Mg and plasma Mg concentration (r 2 ¼ 0.015, P ¼ 0.58).
Plasma Mg concentrations measured at recruitment correlated well with those measured after the test 6-10 weeks later (r 2 ¼ 0.37, P ¼ 0.003), but were on average 6% higher (Figure 2 ). Fractional excretion of the isotopic label within 24 h correlated with total urinary Mg excretion (r 2 ¼ 0.51, Po0.001) (Figure 3 ). By ANOVA, sex, age, weight, plasma Mg concentration and dietary Mg intake did not significantly predict the dependent variables muscle Mg concentration and excretion of the isotopic label.
Discussion
In Mg-deficient patients, the classical (nonisotopic) Mg load test has shown to correlate with muscle Mg concentration (Jones et al., 1969; Lim and Jacob, 1972; Jeppesen, 1986; Holm et al., 1987; Sjogren et al., 1988) . The test is based on Urinary excretion of an intravenousnormal kidney regulation of body stores of Mg, excreting an excess in the normal subject and retaining the mineral in deficiency (Caddell et al., 1984) . Moreover, rat studies have demonstrated that tissues from Mg-deficient rats had a higher Mg uptake after intraperitoneal injection of 28 Mg than controls (Caddell et al., 1981) . The mechanisms by which more Mg is retained in Mg-deficient subjects are unknown, but they may include enhanced renal Mg reabsorption (Rude and Ryzen, 1986 ) and repletion of intracellular Mg stores by increased cellular Mg uptake. During periods of Mg deprivation, Mg homeostasis is maintained by increased reabsorption of Mg in the kidney, increased absorption in the gastrointestinal tract and release from internal Mg stores such as bone and skeletal muscle (Rude, 1998) . The kidney is the organ that most closely regulates Mg homeostasis by adapting Mg reabsorption in the loop of Henle (Quamme, 1997) . Human and animal studies have shown that Mg reabsorption in the kidney is increased in Mg deficiency. An animal study using microperfusion and micropuncture techniques has demonstrated cellular adaptation of Mg transport in the loop of Henle following Mg restriction (Shafik and Quamme, 1989) . This adaptation occurred very rapidly (within 5 h), while plasma Mg did not fall until 20 h after introduction of the Mg restricted diet. Moreover, the response was specific for Mg because there was no effect on Na and Ca transport. Based on studies with isolated distal cells, it was suggested that Mg transport may be controlled by genes that respond to extracellular Mg by the formation of new transporters or channels (Dai et al., 2001) . However, it is unclear if decreased plasma Mg concentration or another mechanism is the trigger for this cellular adaptation. Several depletion studies in man indicate decreased Mg excretion from the start of the depletion period while plasma levels begin decreasing only after several days (Dunn and Walser, 1966; Drenick et al., 1969; Shils, 1969; Lukaski and Nielsen, 2002) .
The Mg load test may provide good information on Mg status, but is time-consuming and requires hospitalization of the subjects. Also, the amount of the Mg load, the length of time of infusion, and the length of time of urine collection has not been standardized (Elin, 1991) and it is difficult to relate the % retention to the total body deficit of Mg. Theoretically, the fractional retention from a given i.v. Mg load should not be dose-nor duration-dependent provided the load does not exceed the renal threshold for Mg (Lasserre et al., 1996) . In the classical load test, a high dose is administered to attenuate the effects of dietary Mg intake and basal urinary Mg as much as possible. When using stable isotopes, the influence of the fluctuations of dietary Mg intake and basal urinary Mg is minimized. However, in the present study, no correlation was found between the fractional excretion of the isotopic label and muscle Mg concentration in healthy subjects.
The findings of our study are subject to several limitations. Kinetic studies with radioactive 28 Mg have shown that parenterally administered Mg is excreted very slowly by the kidneys, but that the overall balance is maintained by a compensatory excretion of endogenous Mg (Aikawa, 1958) . This exchange of the labeled dose with body Mg implicates that only a small part of the administered dose is excreted within 24 h. This amount might be too small to allow the detection of a difference between subjects with different muscle Mg concentrations. Moreover, the amount of excreted isotopic label is a function of total Mg excretion, which depends not only on Mg status but also on the total Mg supplied during the test period (thus including Mg from food) and hormonal variations. Despite standardized meals the amount of total available Mg might have varied among our subjects (e.g. because of differences in intestinal absorption). Muscle Mg concentration is considered as a good indicator for Mg status (Lim et al., 1969; Dyckner and Wester, 1985) . Muscle Mg is lost during Mg deprivation (Drenick et al., 1969; Wallach, 1988; Lukaski and Nielsen, 2002) and an average of 15% of skeletal-muscle Mg can become available for extracellular buffering (Wallach, 1988) . However, there is no reference range for muscle Mg concentration. Depending on the method used for analysis, values can vary considerably. Expressing the results as mmol/100 g FFDS provides greater consistency. It is therefore difficult to judge whether all of our subjects had a sufficient Mg status. The range of muscle Mg in our subjects was 3.50-4.19 mmol/100 g FFDS. Holm et al. (1987) suggested a value of 3.48 mmol/100 g FFDS as cutoff for Mg deficiency. According to this, none of our subjects was Mg deficient. In subjects with normal Mg status, excretion of Mg is not reduced and might thus not correlate with muscle Mg concentration. Similar to our findings, Danielson et al. (1979) found no correlation between the %retention of an infused Mg load and muscle Mg in healthy subjects.
In summary, the results of this study indicate that there is no association between muscle Mg concentration and the excretion of a parenterally administered dose of Mg in subjects with apparently normal Mg status. Although studies Figure 3 Correlation between the excretion of the i.v. 26 Mg dose and total urinary Mg excretion within 24 h.
in subjects with clear Mg deficiency may have shown a correlation, our aim was to develop a test that allows detection of marginal Mg deficiency despite a normal Mg serum concentration. The exchange of the labeled dose with body Mg implicates that only around 8% of the administered dose are excreted within 24 h. This amount may be too small to permit clear distinction between individuals and a longer period of urine collection may be more useful.
